BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21810730)

  • 1. Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality?
    Yerushalmi R; Tyldesley S; Woods R; Kennecke HF; Speers C; Gelmon KA
    Ann Oncol; 2012 Apr; 23(4):876-81. PubMed ID: 21810730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased lymph node positivity in multifocal and multicentric breast cancer.
    Cabioglu N; Ozmen V; Kaya H; Tuzlali S; Igci A; Muslumanoglu M; Kecer M; Dagoglu T
    J Am Coll Surg; 2009 Jan; 208(1):67-74. PubMed ID: 19228505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer multifocality and multicentricity and locoregional recurrence.
    Lynch SP; Lei X; Hsu L; Meric-Bernstam F; Buchholz TA; Zhang H; Hortobágyi GN; Gonzalez-Angulo AM; Valero V
    Oncologist; 2013; 18(11):1167-73. PubMed ID: 24136008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the histopathology and prognosis of bilateral versus unilateral multifocal multicentric breast cancers.
    Kadioğlu H; Özbaş S; Akcan A; Soyder A; Soylu L; Koçak S; Cantürk NZ; Tükenmez M; Müslümanoğlu M
    World J Surg Oncol; 2014 Aug; 12():266. PubMed ID: 25143016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative surgery for multifocal/multicentric breast cancer.
    Nijenhuis MV; Rutgers EJ
    Breast; 2015 Nov; 24 Suppl 2():S96-9. PubMed ID: 26303986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Oncological Safety of Fat Grafting After Breast-Conserving Therapy: A Prospective Study.
    Mestak O; Hromadkova V; Fajfrova M; Molitor M; Mestak J
    Ann Surg Oncol; 2016 Mar; 23(3):776-81. PubMed ID: 26467459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
    Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
    Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy.
    Rakovitch E; Pignol JP; Hanna W; Narod S; Spayne J; Nofech-Mozes S; Chartier C; Paszat L
    J Clin Oncol; 2007 Dec; 25(35):5591-6. PubMed ID: 17984188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local Control of Breast Conservation Therapy versus Mastectomy in Multifocal or Multicentric Breast Cancer: A Systematic Review and Meta-Analysis.
    Fang M; Zhang X; Zhang H; Wu K; Yu Y; Sheng Y
    Breast Care (Basel); 2019 Aug; 14(4):188-193. PubMed ID: 31558892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: single center experience.
    Ustaalioglu BO; Bilici A; Kefeli U; Şeker M; Oncel M; Gezen C; Gumus M; Demirelli F
    Am J Clin Oncol; 2012 Dec; 35(6):580-6. PubMed ID: 21926901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of outcomes of breast conserving therapy in multifocal and unifocal invasive breast cancer.
    Chung AP; Huynh K; Kidner T; Mirzadehgan P; Sim MS; Giuliano AE
    J Am Coll Surg; 2012 Jul; 215(1):137-46; discussion 146-7. PubMed ID: 22608402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which eligible breast conservation patients choose mastectomy in the setting of newly diagnosed breast cancer?
    Adkisson CD; Bagaria SP; Parker AS; Bray JM; Gibson T; Thomas CS; Heckman MG; McLaughlin SA
    Ann Surg Oncol; 2012 Apr; 19(4):1129-36. PubMed ID: 21975859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases".
    Neri A; Marrelli D; Megha T; Bettarini F; Tacchini D; De Franco L; Roviello F
    BMC Surg; 2015 Jan; 15(1):1. PubMed ID: 25586679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Multifocal and Multicentric Breast Cancers.
    Kanumuri P; Hayse B; Killelea BK; Chagpar AB; Horowitz NR; Lannin DR
    Ann Surg Oncol; 2015 Aug; 22(8):2475-82. PubMed ID: 25805233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between patient age, volume of breast tissue excised, and local recurrence.
    Mazeh H; Sagiv I; Katz D; Freund HR; Peretz T; Allweis TM
    J Surg Res; 2013 May; 181(2):187-92. PubMed ID: 22795351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management.
    Tafra L; Essner R; Brenner RJ; Giuliano AE
    Am Surg; 1996 May; 62(5):395-9. PubMed ID: 8615571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of multifocal or multicentric disease on surgery and locoregional, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapy.
    Ataseven B; Lederer B; Blohmer JU; Denkert C; Gerber B; Heil J; Kühn T; Kümmel S; Rezai M; Loibl S; von Minckwitz G
    Ann Surg Oncol; 2015 Apr; 22(4):1118-27. PubMed ID: 25297900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting breast cancer recurrence following breast-conserving therapy: a single-institution analysis consisting of 764 Chinese breast cancer cases.
    Li S; Yu KD; Fan L; Hou YF; Shao ZM
    Ann Surg Oncol; 2011 Sep; 18(9):2492-9. PubMed ID: 21360247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.